 Connection
Nicole Gonzales to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Nicole Gonzales has written about Dose-Response Relationship, Drug.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.151 |
|
|
|
-
Gonzales NR, Shah J, Sangha N, Sosa L, Martinez R, Shen L, Kasam M, Morales MM, Hossain MM, Barreto AD, Savitz SI, Lopez G, Misra V, Wu TC, El Khoury R, Sarraj A, Sahota P, Hicks W, Acosta I, Sline MR, Rahbar MH, Zhao X, Aronowski J, Grotta JC. Design of a prospective, dose-escalation study evaluating the Safety of Pioglitazone for Hematoma Resolution in Intracerebral Hemorrhage (SHRINC). Int J Stroke. 2013 Jul; 8(5):388-96.
Score: 0.073
-
Gonzales NR, Grotta JC. Alteplase for acute ischemic stroke. Expert Rev Cardiovasc Ther. 2006 May; 4(3):301-18.
Score: 0.049
-
Martin-Schild S, Shaltoni H, Abraham AT, Barreto AD, Hallevi H, Gonzales NR, Grotta JC, Savitz SI. Safety of eptifibatide for subcortical stroke progression. Cerebrovasc Dis. 2009; 28(6):595-600.
Score: 0.016
-
Shaltoni HM, Albright KC, Gonzales NR, Weir RU, Khaja AM, Sugg RM, Campbell MS, Cacayorin ED, Grotta JC, Noser EA. Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke? Stroke. 2007 Jan; 38(1):80-4.
Score: 0.013
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|